They sold the debtor's equity of NuGenerex Immuno-Oncology Inc. for $150K to a stalking horse. I guess holders of NGIO shares are co-owners with the stalking horse now.
According to the last public filing, as of April 30, 2021, NGIO had 100,300,000 shares of common stock outstanding of which the debtor owned 64,153,151 shares.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links